About this trial
The objective of this study is to quantify the amount of physical mobilisation provided to patients with moderate to severe acquired brain injury in Scandinavian neuro-ICs, and the association between intensity and duration of mobilisation, physiological data perceived to be related to the safety of high-level mobilisation, and amount of high-level mobilisation during the neuro-ICU stay.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults (age ≥ 18 years)
Admitted to a neuro-ICU or to a regular ICU with dedicated beds for severe acquired brain injury patients in Scandinavia
Patients with moderate to severe traumatic brain injury (TBI) or stroke
Patients must be intubated and expected to require mechanically ventilation for at least 24 hours.
Disqualifiers
Patients that are not likely to survive or for whom a decision has been made on palliative care.
Patients allergic to the Sens monitor patch or showing any type of allergic reactions from the patch after inclusion in the study that needs treatments or results in immediately removal of the patch.
Trial population
Adult patients admitted to a neuro-ICU or to a regular ICU due to moderate to severe traumatic brain injury or stroke.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Amount of physical mobilisation
Amount of physical mobilisation provided during stay at neuro-ICU
Amount of high-level mobilisation
Amount of high-level mobilisation during stay at neuro-ICU
Association between intensity and duration of mobilisation
The association between the intensity and duration of mobilisation during stay at neuro-ICU
Secondary outcomes
Association between frequency of high-level mobilisation and outcomes indicated relevant
Outcomes indicated relevant by clinicians in Scandinavian neuro-ICUs
Sponsors and contacts
Click on the lead sponsor to view all of their trials.